148
Paal TL, Szejtli J (1981) Study of interactions in aqueous-solutions containing cyclodextrin, glucose and borate. Exclusion of the formation of stable D-glucose-cyclodextrin complexes on the
basis or potentiometric and kinetic measurements. Acta Chim Acad Sci Hung 106:9–15
Pitha J, Szente L, Szejtli J (1983) Molecular encapsulation of drugs by cyclodextrins and congeners. In: Bruck SD (ed) Controlled drug delivery, vol I. CRC Press, pp 125–148
Pobozsny K, Kernoczi I, Tetenyi P, Hethelyi I, Szejtli J (1981) Assay of volatile oil- cyclodextrin
complexes by pyrolysis gas-chromatography. Planta Med 42:255–259. https://doi.
org/10.1055/s-2007-971636
Redenti E, Pasini M, Ventura P, Spisni A, Vikmon M, Szejtli J (1994) The terfenadine betacyclodextrin inclusion complex. J Incl Phenom Mol Recognit Chem 15:281–292. https://doi.
org/10.1007/BF00709073
Redenti E, Szente L, Szejtli J (2000) Drug/cyclodextrin/hydroxy acid multicomponent systems.
Properties and pharmaceutical applications. J Pharm Sci 89:1–8. https://doi.org/10.1002/(SICI
)1520-6017(200001)89:1<1::AID-JPS1>3.0.CO;2-W
Redenti E, Szente L, Szejtli J (2001) Cyclodextrin complexes of salts of acidic drugs.
Thermodynamic properties, structural features, and pharmaceutical applications. J Pharm Sci
90:979–986. https://doi.org/10.1002/jps.1050
Richter M, Szejtli J (1966) Photometrische titration der stärkepolysaccharide mit Jod. III. Die
automatische titration. Die Stärke 18:95–100. https://doi.org/10.1002/star.19660180402
Saenger W (1980) Cyclodextrin inclusion-compounds in research and industry. Angewandte
Chemie Int Ed 19:344–362. https://doi.org/10.1002/anie.198003441
Saenger W (1984) Structural aspects of cyclodextrins and their inclusion complexes. In: Atwood JL,
Davies JED, MacNicol DD (eds) Inclusion compounds, vol 2. Academic, London, pp 231–260
Saenger W, Noltemeyer M, Manor PC, Hingerty B, Klar B (1976) “Induced fit” type complex formation of the model enzyme α-cyclodextrin. Bioorg Chem 5:187–195. https://doi.
org/10.1016/0045-2068(76)90007-9
Smolková-Keulemansová E (1982) Cyclodextrins as stationary phases in chromatography. J
Chromatogr 251:17–34
Stadler-Szöke A, Vikmon M, Szemán J, Szejtli J (1984) Examples of the application of cyclodextrin in formulation of oral drug preparations. In: Atwood JL, Davies JED, Osa T (eds)
Clathrate compounds, molecular inclusion phenomena, and cyclodextrins, Advances in
inclusion science. D. Reidel Publishing Company, Dordrecht, pp 503–510. https://doi.
org/10.1007/978-94-009-5376-5
Stadler-Szöke A, Vikmon M, Szejtli J, Kajtár M (1985) Fendiline-beta-cyclodextrin inclusion
complex. J Incl Phenom 3:71–84. https://doi.org/10.1007/BF00658864
Stella VJ, Rajewski RA (1997) Cyclodextrins: their future in drug formulation and delivery. Pharm
Res 14:556–567
Süvegh G, Zsadon B, Szejtli J (1992) Separation of diastereomer vincamine derivative by chromatography on β-cyclodextrin polymer stationary phase. In: Hedges RA (ed) Minutes of the sixth
international symposium on cyclodextrins (Chicago, 21 to 24 April 1992). Éditions de santé,
Paris, pp 584–587
Suzuki M, Fenyvesi É, Szilasi M, Szejtli J, Kajtár M, Szadon B, Sasaki Y (1984) Spectroscopic
investigation of cyclodextrin monomers, derivatives, polymers and azo dyes. In: Atwood JL,
Davies JED, Osa T (eds) Clathrate compounds, molecular inclusion phenomena, and cyclodextrins, Advances in inclusion science. D. Reidel Publishing Company, Dordrecht, pp 715–724.
https://doi.org/10.1007/978-94-009-5376-5
Suzuki M, Szejtli J, Szente L (1989) Inclusion compounds of cyclodextrins and azo dyes. 7.
Molecular-dynamics of derivatives of cyclomalto-oligosaccharides and their complexes with
azo dyes. Carbohydr Res 192:61–68. https://doi.org/10.1016/0008-6215(89)85165-1
Suzuki M, Ohmori H, Kajtár M, Szejtli J, Vikmon M (1994) The association of inclusion complexes of cyclodextrins with azo dyes. J Incl Phenom Mol Recognit Chem 18:255–264. https://
doi.org/10.1007/BF00708732
G. Crini et al.
Paal TL, Szejtli J (1981) Study of interactions in aqueous-solutions containing cyclodextrin, glucose and borate. Exclusion of the formation of stable D-glucose-cyclodextrin complexes on the
basis or potentiometric and kinetic measurements. Acta Chim Acad Sci Hung 106:9–15
Pitha J, Szente L, Szejtli J (1983) Molecular encapsulation of drugs by cyclodextrins and congeners. In: Bruck SD (ed) Controlled drug delivery, vol I. CRC Press, pp 125–148
Pobozsny K, Kernoczi I, Tetenyi P, Hethelyi I, Szejtli J (1981) Assay of volatile oil- cyclodextrin
complexes by pyrolysis gas-chromatography. Planta Med 42:255–259. https://doi.
org/10.1055/s-2007-971636
Redenti E, Pasini M, Ventura P, Spisni A, Vikmon M, Szejtli J (1994) The terfenadine betacyclodextrin inclusion complex. J Incl Phenom Mol Recognit Chem 15:281–292. https://doi.
org/10.1007/BF00709073
Redenti E, Szente L, Szejtli J (2000) Drug/cyclodextrin/hydroxy acid multicomponent systems.
Properties and pharmaceutical applications. J Pharm Sci 89:1–8. https://doi.org/10.1002/(SICI
)1520-6017(200001)89:1<1::AID-JPS1>3.0.CO;2-W
Redenti E, Szente L, Szejtli J (2001) Cyclodextrin complexes of salts of acidic drugs.
Thermodynamic properties, structural features, and pharmaceutical applications. J Pharm Sci
90:979–986. https://doi.org/10.1002/jps.1050
Richter M, Szejtli J (1966) Photometrische titration der stärkepolysaccharide mit Jod. III. Die
automatische titration. Die Stärke 18:95–100. https://doi.org/10.1002/star.19660180402
Saenger W (1980) Cyclodextrin inclusion-compounds in research and industry. Angewandte
Chemie Int Ed 19:344–362. https://doi.org/10.1002/anie.198003441
Saenger W (1984) Structural aspects of cyclodextrins and their inclusion complexes. In: Atwood JL,
Davies JED, MacNicol DD (eds) Inclusion compounds, vol 2. Academic, London, pp 231–260
Saenger W, Noltemeyer M, Manor PC, Hingerty B, Klar B (1976) “Induced fit” type complex formation of the model enzyme α-cyclodextrin. Bioorg Chem 5:187–195. https://doi.
org/10.1016/0045-2068(76)90007-9
Smolková-Keulemansová E (1982) Cyclodextrins as stationary phases in chromatography. J
Chromatogr 251:17–34
Stadler-Szöke A, Vikmon M, Szemán J, Szejtli J (1984) Examples of the application of cyclodextrin in formulation of oral drug preparations. In: Atwood JL, Davies JED, Osa T (eds)
Clathrate compounds, molecular inclusion phenomena, and cyclodextrins, Advances in
inclusion science. D. Reidel Publishing Company, Dordrecht, pp 503–510. https://doi.
org/10.1007/978-94-009-5376-5
Stadler-Szöke A, Vikmon M, Szejtli J, Kajtár M (1985) Fendiline-beta-cyclodextrin inclusion
complex. J Incl Phenom 3:71–84. https://doi.org/10.1007/BF00658864
Stella VJ, Rajewski RA (1997) Cyclodextrins: their future in drug formulation and delivery. Pharm
Res 14:556–567
Süvegh G, Zsadon B, Szejtli J (1992) Separation of diastereomer vincamine derivative by chromatography on β-cyclodextrin polymer stationary phase. In: Hedges RA (ed) Minutes of the sixth
international symposium on cyclodextrins (Chicago, 21 to 24 April 1992). Éditions de santé,
Paris, pp 584–587
Suzuki M, Fenyvesi É, Szilasi M, Szejtli J, Kajtár M, Szadon B, Sasaki Y (1984) Spectroscopic
investigation of cyclodextrin monomers, derivatives, polymers and azo dyes. In: Atwood JL,
Davies JED, Osa T (eds) Clathrate compounds, molecular inclusion phenomena, and cyclodextrins, Advances in inclusion science. D. Reidel Publishing Company, Dordrecht, pp 715–724.
https://doi.org/10.1007/978-94-009-5376-5
Suzuki M, Szejtli J, Szente L (1989) Inclusion compounds of cyclodextrins and azo dyes. 7.
Molecular-dynamics of derivatives of cyclomalto-oligosaccharides and their complexes with
azo dyes. Carbohydr Res 192:61–68. https://doi.org/10.1016/0008-6215(89)85165-1
Suzuki M, Ohmori H, Kajtár M, Szejtli J, Vikmon M (1994) The association of inclusion complexes of cyclodextrins with azo dyes. J Incl Phenom Mol Recognit Chem 18:255–264. https://
doi.org/10.1007/BF00708732
G. Crini et al.